GlassScriptPhysician profile
Mehreen S Iqbal
NPI 1730421165
$7,564.04
in general payments reported to CMS, 2019-2025
25 companies · $3,081 in 2025
The $3,081 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $418 · 2021: $441 · 2022: $510 · 2023: $1,747 · 2024: $363 · 2025: $3,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,043 · Travel and Lodging: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,042.89 |
| Travel and Lodging | $1,147.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,186.25 | 2020-2025 | Proclaim, Ionicrf, Eterna |
| Boston Scientific Corporation | $1,664.73 | 2019-2025 | Wavewriter Alpha Prime 16, General - Dbs, Clinical Trial Product |
| Medtronic, INC. | $1,631.03 | 2021-2025 | Intellis Adaptivestim, Stealthstation S8 Platform, Plasmablade(Tm) |
| Nevro Corp. | $423.17 | 2019-2024 | Senza |
| Globus Medical, INC. | $280.60 | 2025 | Senza |
| Biotronik Nro, INC. | $190.14 | 2025 | Prospera |
| Merz North America, INC. | $157.14 | 2023 | Xeomin |
| Si-Bone, INC. | $140.00 | 2025 | |
| Curonix LLC | $127.75 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Galderma Laboratories, L.P. | $119.99 | 2023-2024 | |
| Merz Pharmaceuticals, LLC | $85.09 | 2023-2025 | Xeomin |
| Medtronic USA, INC. | $85.02 | 2019 | |
| Nalu Medical, INC. | $79.35 | 2025 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $73.06 | 2022 | |
| Bioventus LLC | $65.92 | 2025 | Durolane |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $64.19 | 2023-2024 | |
| Xtant Medical INC | $51.69 | 2025 | |
| Saluda Medical Americas, INC. | $24.18 | 2025 | Evoke |
| Spinal Simplicity, LLC | $23.18 | 2024 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $19.22 | 2025 | Sprint Pns System |
| Electronic Waveform Lab, INC. | $16.55 | 2025 | |
| Depuy Synthes Sales INC. | $16.43 | 2025 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $13.97 | 2020 | |
| Scilex Pharmaceuticals INC. | $12.85 | 2023 | Ztlido |
| Biodelivery Sciences International, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehreen Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.